13:00 - 15:00
ROOM VERDE
CHAIRS: Garcia-Arumi J., Hassan T., Moisseiev J., Steel D.
13:00 - 15:00
ROOM ONICE
CHAIRS: Bressler S., Brucker A., Loewenstein A., Viola F.
13:00 - 14:00
AUDITORIUM
CHAIRS: Loewenstein A., Lumbroso B.,Querques G., Singh R.
13:00 / Variations Of Choroidal
Thickness in neovascularization
Lumbroso B.
13:05 / Imaging of Retinal
Structures: Seeing It Up Close with Adaptive Optics
Kim J.E.
13:10 / The role of
electrophysiology in the assessment of retinal function
Huang S.
13:15 / Multimodal imaging in wet
AMD: fibrocellular vs fibrovascular fenotypes
Querques G.
13:20 / Discussion
13:25 / Metabolic studies in AMD
Borrelli E.
13:30 / Clinicopathologic
correlation of geographic atrophy secondary to age-related
macular degeneration
Dolz-Marco R.
13:35 / Multimodal imaging in
sickle cell retinopathy and incontinentia pigmenti
Liu A.
13:40 / OCT-A and multimodal
integrated evaluation in macular holes: new biomarkers of
surgical outcome?
Bacherini D.
13:45 / Iris vessel changes
assessed with OCT-A in episcleral surgery for retinal
detachment
Mastropasqua R.
13:50 / iOCT in gene therapy
Neubauer J.
13:55 / Discussion
14:00 - 15:00
AUDITORIUM
CHAIRS: Mariotti C., Midena E.
14:00 / Early AMD: novel
functional biomarkers and their correlation with systemic risk
factors
Minnella A.
14:05 / Quantitative optical
coherence tomography angiography biomarkers for neovascular
age-related macular degeneration in remission
Lupidi M.
14:10 / Choriocapillaris flow
voids and outer retinal tubulations in geographic atrophy
Zweifel S.
14:15 / Discussion
14:20 / Update on OCT angiography
in retinal vascular diseases
Schwartz S.G.
14:25 / OCT-A in diabetic
retinopathy
Battaglia Parodi M.
14:30 / Distinguish diabetic
macular edema from capillary non perfusion using two different
OCTA devices
Parravano C.
14:35 / Discussion
14:40 / Multimodal imaging in
hydroxycloroquine toxicity
Pilotto E.
14:45 / Multimodal imaging of
tamoxifen retinopathy focusing on OCT angiographic Findings
Yoon Y.H.
14:50 / OCT-A in Uveitis
Androudi S.
14:55 / Discussion
15:00 - 16:00
AUDITORIUM
CHAIRS: Battaglia- Parodi M., Corcóstegui B., Falcomatà B., Guarnaccia G.
15:00 / State of the art of
Inherited Retinal Dystrophies treatment
Richard G.
15:08 / Indications and evaluation
of patients for gene or stem cell therapy
Brucker A.
15:16 / Surgical procedure for
submacular delivery gene or stem cells therapy
Pertile G.
15:24 / Update on retinal
prosthesis: indications, surgical procedure and results
Patelli F.
15:32 / Digitally enhanced video
assisted surgery for submacular procedure
Devin F.
15:40 / Use of ROCK inhibitors to
prevent photoreceptor-bipolar synaptic disjunction after
retinal detachment
Zarbin M.
15:48 / Discussion
15:00 - 16:00
ROOM ONICE
CHAIRS: Pastor Jimeno J.C., Romano M.
15:00 / A worrisome problem: the
toxicity of perfluorocarbons liquids
Coco Martin R.
15:10 / What do we know about the
retinal toxicity of vital dyes?
Januschowsky K.
15:20 / How to recognize a case of
acute intraocular toxicity
Pastor Jimeno J.C.
15:30 / What do we need to look at
in the choice of intraocular compounds?
Romano M.
15:40 / Can also irrigating
solutions and expandable gases be sources of intra-surgical
toxicity?
Spitzer M.
15:50 / Discussion
15:00 - 18:00
ROOM VERDE
CHAIRS FROM ROOM VERDE:
D’Amico D.J., Dhawahir-Scala F., Rezaei K., Rossi T., Steel D.
CHAIRS FROM ORs:
Kuwait City: Al Sabti K., EL Rayes E.
Mexico City: Fromow J.
Memphis: Brugger J.
SURGEONS:
Kuwait City: Al Sabti K., Chow D., El Rayes E., Maia A.
Memphis: Charles S.
Mexico City: Morales Canton V., Berrocal M.
16:00 - 16:30
COFFEE BREAK
16:30 - 17:30
AUDITORIUM
CHAIRS: Figueroa M., Parolini B., Williamson T.
16:30 / Natural history of serous
retinal detachment in dome-shaped macula
Viola F.
16:35 / OCT-A in myopic CNVs
Pece A.
16:40 / Pathology of the VMI in
myopic foveoschisis
Schumann R.G.
16:45 / Discussion
16:50 / Pearls an Tricks dealing
with myopic Foveoschisis
Mateo C.
16:55 / Myopic Traction
Maculopathy and Lamellar Holes
Figueroa M.
17:00 / Macular buckle
van Meurs J.
17:05 / Discussion
17:10 / Outcome of ILM inverted
flaps and ILM peeling to the edge of the posterior staphyloma
in myopic macular hole retinal detachment
Mortada H.
17:15 / Myopic rhegmatogenous
retinal detachment and macular schisis
Williamson T.
17:20 / Autologous retina graft
for high myopic Macular Holes
Terasaki H.
17:25 / Discussion
16:30 - 18:30
ROOM ONICE
SCIENTIFIC COORDINATORS: Turrisi L., Zucchini D.
16.30 / Introduction
Turrisi L., Zucchini D.
16:40 / New technologies in ophtalmic surgery: nurses skills
Pratesi I., Morroni S.
16.50 / The new integrated vitreoretinal operating theatre
Salonen S.
17.00 / What about Eye Trauma?
Jansen K.
17.10 / Transforming Retinal Surgery Through Pioneering Technology
Bollini S.
17.20 / Driving OR flow optimization and single use through customization of the procedural pack
Vatovec C.
17.30 / Visualization systems in retina surgery
Oller Garcia M.
17.40 / The 3D System in the vitreoretinal surgery
Tescaro S.
17.50 / EVA Upgrade - Dedicated to OR efficiency
Canali F.
18.00 / A phaco for Africa: a humanitarian project
Spiridigliozzi M.
18.10 / Discussion
17:30 - 19:00
AUDITORIUM
CHAIRS: Bressler S., Brucker A., Lanzetta P., Zweifel S.
17:30 / Do baseline systemic
factors affect treatment outcomes in DME and diabetic
retinopathy?
Singh R.
17:35 / Factors that affect vision
or anatomic outcomes when treating DME - what we have learned
in the DRCR.net
Bressler S.
17:40 / The Role of Inflammation
in diabetic macular edema
Kupperman B.
17:45 / Discussion
17:50 / One-Year results of using
a treat-and-extend regimen without a loading phase with
anti-VEGF agents in patients with treatment-naive diabetic
macular edema
Wolf S.
17:55 / Diabetic macular edema
surgery: failure is the only option
D'Amico D.J.
18:00 / Faricimab (RG7716) for
DME: update on phase 2 BOULEVARD study results
Regillo C.D.
18:05 / Discussion
18:10 / A Phase I/II safety and
efficacy study of Anti-PLGF THR-317 in diabetic macular edema
Loewenstein A.
18:15 / Subthreshold micropulse
laser in diabetic macular edema: how it really works
Midena E.
18:20 / New drugs in pipeline for
DME
Boscia F.
18:25 / Discussion
18:30 / Panel cases discussant
Kupperman B., Singh R.
18:00 - 19:00
ROOM VERDE
CHAIR: Claes C.
SPEAKERS: Bali E., Hassan T., Kulikov A., Malachkova N., Mortada H., Mura M., Quiroz-Mercado H., Rezaei K., Gini G.
Stanislao Rizzo (Italy)
Francesco Faraldi (Italy)
Carl Claes (Belgium)
José García-Arumí (Spain)
Kourous A. Rezaei (USA)
Ramin Tadayoni (France)
Albert Augustin (Germany)
Ehab EL Rayes (Egypt)
Stanislao RIZZO
AOUC Azienda Ospedaliero-Universitaria Careggi,
Florence (Italy)
Francesco BARCA
Tomaso CAPOROSSI
AOUC Azienda Ospedaliero-Universitaria Careggi,
Florence (Italy)
Daniela BACHERINI
Andrea GIORNI
Dario MUCCIOLO
Alfonso SAVASTANO
AOUC Azienda Ospedaliero-Universitaria Careggi,
Florence (Italy)
AIM Group International
Florence Office
Viale G. Mazzini 70
50132 Florence (Italy)
Tel: +39 055 233881
Fax: +39 055 3906908